Quarterly report [Sections 13 or 15(d)]

STOCK WARRANTS STOCK OPTIONS AND RESTRICTED STOCK UNITS (Details Narrative)

v3.25.3
STOCK WARRANTS STOCK OPTIONS AND RESTRICTED STOCK UNITS (Details Narrative) - USD ($)
 1 Months Ended 3 Months Ended 9 Months Ended 12 Months Ended
Jan. 15, 2025
Jun. 04, 2024
Apr. 11, 2024
Mar. 06, 2024
Jul. 17, 2025
Oct. 18, 2024
Jun. 30, 2024
Jun. 24, 2024
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Dec. 31, 2024
Oct. 31, 2024
Jan. 31, 2022
Oct. 24, 2019
common stock, par value                 $ 0.00001   $ 0.00001   $ 0.00001      
Retained earnings (Accumulated Deficit)                 $ (104,440,303)   $ (104,440,303)   $ (98,328,395)      
Net income                 $ (2,186,624) $ (1,841,206) (6,061,155) $ (6,424,492)        
Stock based compensation expense                     $ 370,181 $ 584,551        
2019 Equity Incentive Plan [Member]                                
Number of authorized share increased         350,000                      
Series A Warrants [Member]                                
True-up Payment due to the remaining holders     $ 1,640,000                          
True-up payment     $ 1,640,000                          
Additional warrants issued     110,273                          
Floor price of warrant shares     $ 7.60                          
Floor price of true up payment     $ 4.71                          
PIPE 2024 Offering [Member]                                
Common stock, units issued                           202,470    
Common stock, units issued, price per share                           $ 40.50    
common stock, par value                           0.00001    
Common stock, issued during period           19,110         579,219   162,129      
Proceeds from issuance of common stock           $ 902,541         $ 3,680,411   $ 1,652,034      
Exercise price                           $ 38    
Weighted-average exercise price           $ 47.30     $ 8.39   $ 8.39   $ 9.60      
Exercise price warrant decrease       $ 682                        
PIPE 2024 Offering [Member] | Series A Warrants [Member]                                
Additional warrants issued 225,450                              
Common stock, issued during period                         1,603,370      
Exercise price $ 8.29                              
Exercise price warrant decrease $ 8.29                              
PIPE 2024 Offering [Member] | Series B Warrants [Member]                                
Common stock, issued during period                         640,864      
Restricted Stock Units [Member]                                
Unrecognized compensation expense                 $ 15,524   $ 15,524          
Vested                       105        
Weighted avaerage unrecognized compensastion cost                     5 years          
Stock based compensation expense                 $ 15,524 15,524 $ 46,571 $ 46,571        
Unvested RSUs granted to executive officers                 90   90   90      
RSUs vested outstanding executive officers                 869   869   702      
RSUs unvested outstanding executive officers                 84   84   251      
Weighted average remaining contractual life                     6 years 2 months 12 days   6 years 2 months 12 days      
Restricted Stock Units [Member] | Minimum [Member] | Executive Officer [Member]                                
Exercise price                 $ 528   $ 528   $ 528      
Restricted Stock Units [Member] | Maximum [Member] | Executive Officer [Member]                                
Exercise price                 $ 2,552   $ 2,552   $ 2,552      
Stock Options [Member]                                
Stock options to acquire shares of common stock                 1,256   1,256   1,323      
Vested option shares                 1,167   1,167   1,048      
NonVested option shares                 89   89   275      
Unrecognized compensation expense                 $ 119,143   $ 119,143          
Weighted avaerage unrecognized compensastion cost                     3 years          
Stock based compensation expense                 $ 99,727 $ 168,720 $ 323,609 $ 537,980        
Warrant Inducement [Member]                                
Exercise price             $ 297                  
Number of warrants to purchase common stock             18,763                  
Total gross proceeds             $ 2,786,174                  
Net proceeds             2,425,418                  
Retained earnings (Accumulated Deficit)             341,297                  
Deemed dividend amount             1,455,805                  
Commissions and transaction costs   $ 42,539         $ 360,756                  
Warrants issued             9,382                  
Exercise price warrant decrease   $ 297         $ 297                  
Stock Warrant [Member]                                
Number of authorized shares                             1,576  
Authorization of shares of common stock             3,182                 1,167
Stock Warrant [Member] | Consulting Agreement [Member]                                
Common stock, issued during period             5,184                  
Common stock, shares issued               4,198                
Existing warrants shares             9,382                  
Outstanding and reserved shares             4,198                  
Armistice Warrants [Member]                                
Exercise price       $ 1,485                        
Net income       $ 23,270                        
Reduced current warrant exercise price per share       $ 1,485                        
Description of warrants       Warrants as a result of the Inducement Letters, the Company issued an aggregate 2,418 warrants (the “Armistice Warrants”) consisting of (i) 1,934 warrants pursuant to the Adjustment terms under the September 2021 Armistice Warrant, and (ii) 484 warrants pursuant to the Adjustment terms of the March 2022 Armistice warrant                        
Exercise price warrant decrease       $ 682